The Lifestar Institute published a paper “The Demographic and Biomedical Case for Late-Life Interventions in Aging,” in the July 14 issue of the journal Science Translational Medicine.

The scientific panel proposes that the United States and nations across the world create a global collaboration and launch an Apollo-like Project with the following goal: translate laboratory knowledge about the degenerative changes of aging into new kinds of medicines for humans that can prevent and repair those changes.

The panel urges governments and the biomedical industry to fund three key initiatives: (1) Use public health agencies to inform citizens on how they can improve their lifestyles. (2) Develop the first genuine anti-aging medicines that are able to boost the body’s ability to maintain health (3) Develop and apply regenerative methods that can remove, replace, repair, and neutralize the cellular and molecular damage that accumulate in aging bodies and restore youthful structure and function.

The full paper is available below:

The Demographic and Biomedical Case for Late-Life Interventions in Aging